©The Author(s) 2026.
World J Gastrointest Oncol. Feb 15, 2026; 18(2): 115944
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.115944
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.115944
Table 2 Overview of experimental and clinical studies assessing the effects of sevoflurane on gastric cancer biology and immune responses
| Ref. | Key findings | Method |
| Chen et al[20] | Increased miR-34a → Suppression of TGIF2 → Reduced EMT and invasion | In vitro |
| Liu and Chen[21] | Tumor suppression via DLX6-AS1/epigenetic modulation through ZC3H13 knockdown | In vitro |
| Yong et al[23] | Decreased FOXP3 expression in tumor cells leads to reduced invasion | In vitro |
| Yong et al[22] | Increased CD4+CD25+FOXP3+ Treg cells; indicates immune modulation | Clinical study |
- Citation: Arun O, Arun F. Does anesthesia choice shape oncologic destiny in gastric cancer surgery? World J Gastrointest Oncol 2026; 18(2): 115944
- URL: https://www.wjgnet.com/1948-5204/full/v18/i2/115944.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i2.115944